Eurofins DiscoverX
James Costantin is a Scientific Market Development Manager specializing in Ion Channels. With a background in Neuroscience, James has held various roles in companies such as Eurofins DiscoverX, Nanion Technologies, and Molecular Devices. James played a key role in the development and launch of automated electrophysiology instruments, consistently driving growth and success in the North American market. James has a strong academic foundation, earning degrees from University of California, Berkeley, UCLA, The University of Texas Health Science Center at Houston, and University of Rochester.
Eurofins DiscoverX
DiscoveRx:registered: is an innovative company that develops, manufactures, and commercializes reagents, complete cell-based assay kits, profiling and screening services as well as other turn-key solutions for the drug discovery, screening, and life science markets. Our biochemical and cell-based assays enable customers to improve researchproductivity and effectiveness of their screening, lead optimization and SAR campaigns, thus accelerating the discovery and development of new drug